IAVI 008

Status:Completed

Phase:I

Principal Investigator(s):

Objective:Evaluate the safety and immunogenicity of a candidate HIV-1 clade A MVA-based vaccine, MVA.HIVA, delivered intradermally in HIV-negative adult volunteers previously vaccinated in IAVI 002

Prevention Option(s):HIV Vaccine

Study Design:Open label

Arms and Assigned Interventions

DescriptionCandidate HIV-1 clade A MVA-based vaccine, MVA.HIVA, delivered intradermally in HIV-negative adult volunteers previously vaccinated with pTHr.HIVA vaccine

Mode of DeliveryIntradermal

ARMs

Official Code: IAVI 008

Trial Sponsors: Kenya AIDS Vaccine Initiative-Kenyatta National Hospital (KAVI-KNH)

Start Date

End Date

none

Enrollment:10

Age range: ↔ any

Population:

Stay up-to-date!